Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: Findings, results, and indications

被引:35
|
作者
Kim, H. Jeffrey [1 ,2 ,6 ]
Hagan, Marygrace [3 ]
Butman, John A. [4 ]
Baggenstos, Martin [3 ]
Brewer, Carmen [1 ,2 ]
Zalewski, Christopher [1 ,2 ]
Linehan, W. Marston [5 ]
Lonser, Russell R. [3 ]
机构
[1] Natl Inst Deafness & Other Commun Disorders, Off Clin Director, NIH, Bethesda, MD USA
[2] Natl Inst Deafness & Other Commun Disorders, Otolaryngol Branch, NIH, Bethesda, MD USA
[3] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA
[4] NIH, Dept Diagnost Radiol, Ctr Clin, Bethesda, MD 20892 USA
[5] NIH, Urol Oncol Branch, Natl Canc Ctr, Bethesda, MD 20892 USA
[6] Georgetown Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, Washington, DC 20007 USA
基金
美国国家卫生研究院;
关键词
Endolymphatic sac tumor; von Hippel-Lindau; hearing loss; outcome; vertigo; surgery; MORBID HEARING-LOSS; COCHLEAR IMPLANTATION; TEMPORAL BONE; ADENOCARCINOMA; ORIGIN; GENE;
D O I
10.1002/lary.23646
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/Hypothesis: To define the surgical treatment and outcomes of von Hippel-Lindau (VHL) disease-associated endolymphatic sac tumors (ELSTs), we analyzed consecutive VHL patients who underwent ELST resection. Study Design: Retrospective investigation of consecutive VHL patients who underwent resection of ELSTs at a clinical research center between 1999 and 2010. Methods: Analysis of serial clinical examinations, audiograms, imaging studies, and operative findings were analyzed. Results: Thirty-one consecutive patients with ELSTs (15 males, 16 females) underwent resection of 33 tumors (mean follow-up, 49.9 +/- 48.0 months; range, 1.0116 months). One patient had bilateral ELST resections and one patient underwent reoperation for recurrence. Mean age at surgery was 38.2 +/- 10.2 years (range, 1267 years). Whereas 29 ears (88%) had direct radiographic evidence of an ELST, four ears (12%) did not. Mean tumor size was 1.3 +/- 1.1 cm (range, 0.25.2 cm). Whereas two patients (two ears, 6%) were asymptomatic, 29 patients (31 ears, 94% of ears) had associated audiovestibular symptoms, including sensorineural hearing loss (28 ears, 84%), tinnitus (24 ears,73%), and vertigo (21 patients, 68%). Postoperatively, hearing was stabilized (27) or improved (three) in 97% of 31 ears. Complete tumor resection was achieved in 30 ears (91% of 33 ears). Complications included cerebrospinal fluid leak in two ears (6%) and transient lower cranial nerve palsy in one ear (3%). Conclusions: Surgical resection of ELSTs can be performed with hearing preservation and a reduction in audiovestibular dysfunction. Early surgical resection can prevent or decrease disabling audiovestibular symptoms, enhance the opportunity for complete resection, and preserve hearing. Laryngoscope, 2012
引用
收藏
页码:477 / 483
页数:7
相关论文
共 50 条
  • [21] Conservative management of endolymphatic sac tumors in von Hippel–Lindau disease: case report
    Matthieu Peyre
    Stephan Gaillard
    Remy van Effenterre
    Sophie Giraud
    Stéphane Richard
    Acta Neurochirurgica, 2011, 153 : 42 - 47
  • [22] De Novo Development and Progression of Endolymphatic Sac Tumour in von Hippel-Lindau Disease: An Observational Study and Literature Review
    Eze, Nwaneka
    Huber, Alexander
    Schuknecht, Bernhard
    JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2013, 74 (05) : 259 - 265
  • [23] Differential grading of endolymphatic sac tumor extension by virtue of von Hippel-Lindau disease status
    Bambakidis, NC
    Megerian, CA
    Ratcheson, RA
    OTOLOGY & NEUROTOLOGY, 2004, 25 (05) : 773 - 781
  • [24] Endolymphatic sac tumor and angiomatous lesions of the nasal and pharyngeal mucosa as a first manifestation of von Hippel-Lindau disease
    Honeder, Clemens
    Gstoettner, Wolfgang
    Matula, Christian
    Czerny, Christian
    Gruber, Andreas
    Ramsebner, Reinhard
    Arnoldner, Christoph
    LARYNGOSCOPE, 2012, 122 (10) : 2300 - 2303
  • [25] Endolymphatic Sac Tumors Associated With von Hippel-Lindau: A Case Report Highlighting Opportunity for Novel Orphan Drug Therapy
    Tan, Donald
    Fujiwara, Rance J. T.
    Tan, Christopher
    Isaacson, Brandon
    Hunter, Jacob B.
    OTOLOGY & NEUROTOLOGY, 2024, 45 (09) : e644 - e646
  • [26] A histopathological connection between a fatal endolymphatic sac tumour and von Hippel-Lindau disease from 1960
    Bellairs, J. A.
    Gluth, M. B.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2018, 132 (01) : 75 - 78
  • [27] Endolymphatic sac tumours and von Hippel-Lindau disease - case report, molecular analysis and histopathological characterization
    Krzystolik, K.
    Cybulski, C.
    Sagan, L.
    Nowacki, P.
    Lubinski, J.
    FOLIA NEUROPATHOLOGICA, 2009, 47 (01) : 75 - 80
  • [28] Von Hippel-Lindau Disease
    Findeis-Hosey, Jennifer J.
    McMahon, Kelly Q.
    Findeis, Sarah K.
    JOURNAL OF PEDIATRIC GENETICS, 2016, 5 (02) : 116 - 123
  • [29] Von Hippel-Lindau disease: a single gene, several hereditary tumors
    Crespigio, J.
    Berbel, L. C. L.
    Dias, M. A.
    Berbel, R. F.
    Pereira, S. S.
    Pignatelli, D.
    Mazzuco, T. L.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2018, 41 (01) : 21 - 31
  • [30] Von Hippel-Lindau disease (vHL)
    Binderup, Marie Louise Molgaard
    Bisgaard, Marie Luise
    Harbud, Vibeke
    Moller, Hans Ulrik
    Gimsing, Steen
    Friis-Hansen, Lennart
    Hansen, Thomas van Overeem
    Bagi, Per
    Knigge, Ulrich
    Kosteljanetz, Michael
    Bogeskov, Lars
    Thomsen, Carsten
    Gerdes, Anne-Marie
    Ousager, Lillian Bomme
    Sunde, Lone
    DANISH MEDICAL JOURNAL, 2013, 60 (12):